In the study, we found that brusatol was capable of enhancing the anti-tumor effects of lapatinib in HER2-positive SK-BR-3, AU565 and SK-OV-3 cancer cells in a synergistic manner. The gene discussed is ERBB2; the disease is neoplasm.